PortfoliosLab logoPortfoliosLab logo
**Elite (Top Selection)
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Diversification

Asset Allocation


ANET 10.00%ASML 10.00%EXEL 10.00%FTNT 10.00%GOOGL 10.00%KLAC 10.00%LLY 10.00%NBIX 10.00%NVMI 10.00%UTHR 10.00%EquityEquity

Benchmark: S&P 500 Index · Rebalance: Every 3 months

Portfolio Optimizer

Find the right asset allocation for **Elite (Top Selection)

Add portfolio to the optimizer to find optimal allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in **Elite (Top Selection), comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends. The portfolio is rebalanced Every 3 months.


Loading charts...

Benchmark

Compare your portfolio against anything

Returns By Period

As of Aug 1, 2026, the Elite (Top Selection) returned 36.15% Year-To-Date and 34.65%** of annualized return in the last 10 years.


Position1D1M6MYTD1Y3Y*5Y*10Y*ALL TIME*
Benchmark
S&P 500 Index
0.70%0.09%7.94%9.41%18.15%17.84%11.25%13.26%8.09%
Portfolio
**Elite (Top Selection)
-0.25%-6.56%24.79%36.15%79.46%44.11%33.97%34.65%34.83%
ANET
Arista Networks, Inc.
5.46%8.24%27.24%37.64%46.36%57.23%49.97%45.01%38.48%
ASML
ASML Holding N.V.
-1.36%-11.50%15.03%53.00%136.03%33.26%17.48%32.27%26.74%
EXEL
Exelixis, Inc.
-5.25%-1.72%28.22%20.99%46.41%39.27%25.77%19.21%4.71%
FTNT
Fortinet, Inc.
4.99%1.87%99.30%103.94%62.11%27.56%24.36%37.30%31.37%
GOOGL
Alphabet Inc. Class A
6.73%-1.41%5.50%13.93%86.11%39.78%21.67%24.55%25.41%
KLAC
KLA Corporation
1.38%-31.32%28.36%50.85%109.32%53.92%40.75%39.77%22.49%
LLY
Eli Lilly and Company
-0.53%-3.60%11.14%7.26%56.33%37.33%37.67%32.12%16.04%
NBIX
Neurocrine Biosciences, Inc.
-10.08%-0.58%22.59%17.61%30.08%17.27%12.34%12.71%9.11%
NVMI
Nova Ltd
-0.81%-22.23%-14.63%19.03%48.85%45.70%31.93%42.36%12.41%
UTHR
United Therapeutics Corporation
-1.54%-5.38%10.27%6.25%88.46%29.19%23.26%15.19%17.35%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Monthly Returns

Based on dividend-adjusted daily data since Jun 6, 2014, Elite (Top Selection)'s average daily return is +0.13%, while the average monthly return is +2.68%. At this rate, an investment would double in approximately 2.2 years**.

Historically, 67% of months were positive and 33% were negative. The best month was Apr 2020 with a return of +15.6%, while the worst month was Oct 2018 at -11.3%. The longest winning streak lasted 11 consecutive months, and the longest losing streak was 3 months.

On a daily basis, Elite (Top Selection) closed higher 56% of trading days. The best single day was Apr 9, 2025 with a return of +10.1%, while the worst single day was Mar 16, 2020 at -10.9%**.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20269.10%-0.04%-2.54%12.43%11.44%12.36%-9.00%36.15%
20258.27%-4.04%-9.76%3.86%4.80%8.29%-2.09%3.24%15.57%7.13%3.40%-0.27%42.61%
20244.80%7.57%3.57%-2.60%7.11%8.73%-3.63%6.86%-2.56%-0.81%3.74%1.49%38.77%
20235.04%-1.98%9.85%-1.62%6.53%4.27%3.78%3.27%-4.40%-1.57%9.79%6.07%45.17%
2022-10.74%0.35%6.15%-9.19%4.11%-3.65%9.31%-6.82%-7.02%6.34%12.09%-6.59%-8.67%
20218.02%5.10%2.52%5.74%1.95%2.31%3.83%7.11%-5.06%9.69%-0.23%8.56%60.99%

Benchmark Metrics

**Elite (Top Selection) has an annualized alpha of 20.51%, beta of 1.12, and R2 of 0.66 versus S&P 500 Index. Calculated based on daily prices since June 06, 2014.

  • This portfolio captured 173.36% of S&P 500 Index gains but only 72.34% of its losses - a favorable profile for investors.
  • This portfolio generated an annualized alpha of 20.51% versus S&P 500 Index - delivering returns beyond what market exposure alone would predict.
  • With beta of 1.12 and R2 of 0.66, this portfolio moves broadly in line with S&P 500 Index - much of its variation is explained by market exposure rather than independent behavior.

Alpha
20.51%
Beta
1.12
0.66
Upside Capture
173.36%
Downside Capture
72.34%

Expense Ratio

**Elite (Top Selection) has an expense ratio of 0.00%, meaning no management fees are charged. Below, you can find the expense ratios of the portfolio's funds side by side and easily compare their relative costs.


The portfolio doesn't include any funds that charge management fees.

Return for Risk

Risk / Return Rank

Elite (Top Selection) ranks 96 for risk / return — above 96% of Portfolios** peers on PortfoliosLab. Its historical combined result is among the stronger results in the peer group.


**Elite (Top Selection) Risk / Return Rank: 9696
Overall Rank
**Elite (Top Selection) Sharpe Ratio Rank: 9797
Sharpe Ratio Rank
**Elite (Top Selection) Sortino Ratio Rank: 9595
Sortino Ratio Rank
**Elite (Top Selection) Omega Ratio Rank: 9595
Omega Ratio Rank
**Elite (Top Selection) Calmar Ratio Rank: 9898
Calmar Ratio Rank
**Elite (Top Selection) Martin Ratio Rank: 9797
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

Risk / Return Metrics

The table below presents risk-adjusted performance metrics for **Elite (Top Selection) and compares them with S&P 500 Index.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


PortfolioBenchmarkDifference
Sharpe ratioReturn per unit of total volatility

3.33

1.42

+1.91

Sortino ratioReturn per unit of downside risk

4.01

1.98

+2.03

Omega ratioGain probability vs. loss probability

1.51

1.25

+0.26

Calmar ratioReturn relative to maximum drawdown

7.33

2.00

+5.32

Martin ratioReturn relative to average drawdown

24.91

8.49

+16.41


How much return does each position deliver for the risk it carries? Higher values mean better reward for the risk taken.

PositionRisk / Return RankSharpe ratioSortino ratioOmega ratioCalmar ratioMartin ratio
ANET
Arista Networks, Inc.
71
0.831.441.181.643.37
ASML
ASML Holding N.V.
96
2.983.371.416.2321.34
EXEL
Exelixis, Inc.
83
1.331.931.252.838.84
FTNT
Fortinet, Inc.
81
1.371.881.292.554.11
GOOGL
Alphabet Inc. Class A
94
2.703.701.464.1111.67
KLAC
KLA Corporation
87
1.852.251.312.529.80
LLY
Eli Lilly and Company
83
1.482.101.282.446.60
NBIX
Neurocrine Biosciences, Inc.
71
0.911.381.191.453.18
NVMI
Nova Ltd
71
0.831.361.171.254.35
UTHR
United Therapeutics Corporation
95
1.894.331.496.7115.67

Sharpe Ratio

The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk. Learn how to interpret the Sharpe ratio.

The current **Elite (Top Selection) Sharpe ratio is 3.33 as of Aug 1, 2026 (the value is recalculated daily), calculated over the past 12 months.

Compared to the broad market, where average Sharpe ratios range from 1.18 to 2.00, this portfolio's current Sharpe ratio is in the top 25%. This signifies superior risk-adjusted performance, meaning the portfolio is delivering strong returns for the level of risk taken compared to most others.

The chart below shows the rolling Sharpe ratio of **Elite (Top Selection) compared to the selected benchmark. This view highlights how the investment's risk-adjusted performance has changed over time.


Loading charts...

Dividends

Dividend yield

**Elite (Top Selection) provided a 0.18% dividend yield over the last twelve months.


PositionTTM20252024202320222021202020192018201720162015
Portfolio0.18%0.24%0.29%0.26%0.36%0.26%0.36%0.51%0.61%0.53%0.64%0.60%
ANET
Arista Networks, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
ASML
ASML Holding N.V.
0.56%0.97%0.97%0.86%1.27%0.50%0.50%1.40%0.94%0.64%0.92%0.73%
EXEL
Exelixis, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
FTNT
Fortinet, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
GOOGL
Alphabet Inc. Class A
0.24%0.27%0.32%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
KLAC
KLA Corporation
0.44%0.61%0.96%0.92%1.25%0.91%1.35%1.74%3.17%2.15%2.67%2.94%
LLY
Eli Lilly and Company
0.56%0.56%0.67%0.78%1.07%1.23%1.75%1.96%1.94%2.46%2.77%2.37%
NBIX
Neurocrine Biosciences, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
NVMI
Nova Ltd
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
UTHR
United Therapeutics Corporation
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading charts...

Worst Drawdowns

The table below displays the maximum drawdowns of the **Elite (Top Selection). A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the **Elite (Top Selection) was 27.42%, occurring on Mar 16, 2020. Recovery took 31 trading sessions.

The current Elite (Top Selection) drawdown is 9.00%**.


Drawdown

Fall

Recovery

Underwater

Related event

-27.42%Mar 2020
1mo 1d1mo 14d
2mo 15dFeb 2020 - Apr 2020
COVID crash2020
-23.76%Apr 2025
2mo 15d2mo 23d
5mo 8dJan 2025 - Jun 2025
2025 selloff2025
-23.34%Dec 2018
3mo 26d2mo 25d
6mo 21dAug 2018 - Mar 2019
Rate-hike selloffLate 2018
-22.63%Oct 2022
9mo 20d5mo 17d
1y 3moDec 2021 - Mar 2023
Bear market2022
-20.34%Feb 2016
6mo 21d3mo 22d
10mo 13dJul 2015 - May 2016

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading charts...

Diversification

Diversification Metrics


Number of Effective Assets

The portfolio contains 10 assets, with an effective number of assets of 10.00, reflecting the diversification based on asset allocation. Your capital is spread almost evenly across your holdings, indicating a well-balanced allocation. Note that true diversification also depends on the correlations between assets — check the diversification ratio below.


Diversification Ratio
1Y
3Y
5Y
10Y
All Time
Diversification Ratio

1.92

1.79

1.68

1.61

1.65

The portfolio has a diversification ratio of 1.65, in line with the typical range across portfolios.

**Elite (Top Selection) correlation to the S&P 500 Index

**Elite (Top Selection) has a 0.76 correlation to S&P 500 Index over the trailing 12 months. This section compares each holding's correlation to the benchmark and to the portfolio.

Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.76

Correlation (3Y)
Balances recent behavior with more history.

0.77

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.81

Correlation (10Y)
Provides a long-term view across more market conditions.

0.77

Correlation (All Time)
Calculated using the full available price history since Jun 6, 2014

0.76


Benchmark Correlations

Correlation vs. S&P 500 Index. GOOGL has the highest benchmark correlation at 0.68, while UTHR has the lowest at 0.32.

UTHR
0.32
NBIX
0.36
EXEL
0.37
LLY
0.38
NVMI
0.55
ANET
0.55
FTNT
0.56
ASML
0.66
KLAC
0.66
GOOGL
0.68

Portfolio Correlations

Correlation vs. **Elite (Top Selection). KLAC has the highest portfolio correlation at 0.73, while LLY has the lowest at 0.42.

LLY
0.42
UTHR
0.46
EXEL
0.57
NBIX
0.57
GOOGL
0.60
FTNT
0.62
ANET
0.66
NVMI
0.67
ASML
0.71
KLAC
0.73

Asset Correlations Table

See how each holding historically moved in relation to the other holdings, the portfolio, and the selected benchmark.

Based on daily historical returns since Jun 6, 2014
Diversification Analysis

Find what **Elite (Top Selection) is missing

See which holdings overlap, where **Elite (Top Selection) is concentrated, and which low-correlation assets could fill the gaps.

Analyze Diversification